Every plan price printed, one price at every dose, 503A pharmacies named on its own pages
Released: · Last reviewed:
As of November 6, 2026, and unchanged on our November 20, 2026 re-read, NexLife charges $129 a month month-to-month for compounded tirzepatide, or $125, $119 and $115 a month on 3-, 6- and 12-month plans, the same price at every dose with no membership fee; its 12-month plan ($1,380, paid upfront) puts it first in our computed 12-month cost order.
Price check: Mondae charges $126 month to month ($114 a month on 6-month plans) and Collective $69 a month plus a $199 yearly membership; Eden charges $129, the same as NexLife (read November 20, 2026). FDA sent NexLife a warning letter about its website claims on June 8, 2026 (see below).
| Product | Price shown | Basis / conditions | Source | Read |
|---|---|---|---|---|
| Compounded tirzepatide | $129 / $125 / $119 / $115 a month | month-to-month / 3 / 6 / 12-month plans; same price at every dose | nexlife.us | Nov 6, 2026 |
| Compounded semaglutide | $109 / $105 / $99 / $95 a month | month-to-month / 3 / 6 / 12-month plans; same price at every dose | nexlife.us | Nov 6, 2026 |
| Microdose tirzepatide | $129 / $125 / $119 / $115 a month | plan tiles; the same as the standard plan since November 8, 2026 | nexlife.us | Nov 8, 2026 |
| Microdose semaglutide | $109 / $105 / $99 / $95 a month | plan tiles; the same as the standard plan since November 8, 2026 | nexlife.us | Nov 8, 2026 |
| Sublingual tirzepatide (ODT) | $229 / $219 / $205 / $199 a month | month-to-month / 3 / 6 / 12-month plans | nexlife.us | Nov 20, 2026 |
| Sublingual semaglutide (ODT) | $199 / $185 / $177 / $165 a month | month-to-month / 3 / 6 / 12-month plans | nexlife.us | Nov 20, 2026 |
| Billing | month to month billed monthly; 3-, 6- and 12-month plans "paid upfront, in full, at checkout" | FAQ (updated Nov 14, 2026); plan pages say plans "continue monthly unless canceled" | nexlife.us (source) | Nov 20, 2026 |
| Pharmacies | two named on its FAQ; three on its plan pages | Absolute Pharmacy and Boudreaux's New Drug Store (FAQ, pharmacy page); plan pages add Premium Compounding | nexlife.us (source) | Nov 20, 2026 |
| States served | 45 states and D.C. (FAQ) | its states page says all 50 states and D.C.; the FAQ excludes AL, LA, MS, VA and WV | nexlife.us (source) | Nov 20, 2026 |
On the 12-month plan, compounded tirzepatide works out to 12 × $115 = $1,380 for the year; staying month-to-month costs 12 × $129 = $1,548, or $168 more. For semaglutide the figures are $1,140 (12 × $95) and $1,308 (12 × $109). Because the price does not change with dose, these totals hold at 2.5 mg and at 15 mg.
NexLife's plan pages say cancellations take effect after 30 days, so you may receive and pay for one more shipment unless NexLife Medical Group approves stopping sooner for medical reasons. On 3-, 6- and 12-month plans, unshipped months are refunded. Any authorization charge is refunded if you are not prescribed; once medication ships, the order is final.
The policy page refunds program and membership fees, not medication, if a member loses less than 5% of starting weight over six months, with conditions: enrolled on or after January 1, 2026, 180 consecutive days with no refill gaps, weight logged at least every two weeks, a starting BMI of 30 or more, and a claim filed between day 181 and day 210. NexLife's microdose and sublingual plan pages still carry broader money-back wording that does not match this, so we quote the policy page.
FDA's warning letter 730096 to Nexlife Inc., dated June 8, 2026 and posted June 16, 2026, said representations on its website about compounded semaglutide and tirzepatide were false or misleading, and that the pictured labels identified "Nexlife" as if it were the compounder, which it is not (FDA, read November 20, 2026). NexLife says it responded and that, as of November 12, 2026, FDA had not published a close-out letter. A warning letter is not a recall or a license action; it asks the company to correct the issues.
Since our October review, NexLife has published a Price Match Guarantee for new members who switch with an active compounded tirzepatide or semaglutide prescription: it matches the other provider's regular all-in month-to-month price, but not first-month offers, coupons or prepaid rates, and not for people with Medicare, Medicaid or TRICARE (terms, read November 20, 2026).
People who want to know the full monthly price before they apply, a price that does not climb with the dose, and the names of the pharmacies that fill the prescription.
Computed order: 1 of 5 ($1,380 for 12 months of compounded tirzepatide). Featured pick: an editorial selection.
Related: November 2026 price index · how programs screen patients · how we rank · all reviews